| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $9.7M | -20.9% |
| SG&A Expense | $6.0M | -16.8% |
| Operating Income | -$15.7M | +19.4% |
| Interest Expense | $27K | -52.0% |
| Income Tax | $0 | — |
| Net Income | -$16.8M | +9.7% |
| EPS (Basic) | -$47.14 | +54.5% |
| EPS (Diluted) | -$47.14 | +54.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.8M | +110.0% |
| Current Assets | $7.1M | +59.2% |
| Total Assets | $7.3M | +41.1% |
| Current Liabilities | $2.8M | -20.6% |
| Total Liabilities | $9.3M | +163.9% |
| Stockholders' Equity | -$2.0M | -223.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.3M | +26.2% |
| Capital Expenditures | $22K | -38.9% |
| Investing Cash Flow | -$22K | +38.9% |
| Financing Cash Flow | $16.4M | +3.1% |
| Free Cash Flow | -$13.4M | +26.2% |